D-1448-2016 Class II Terminated
FDA drug recall D-1448-2016 was initiated by Actavis Inc on Jul 11, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Feb 16, 2017). Affected quantity: 8,062 units.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 3, 2016
- Initiation Date
- Jul 11, 2016
- Termination Date
- Feb 16, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,062 units
Product description
Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA; Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
Lot #: 3803J141, Exp. 7/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1448-2016
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026